Int J Oncol. 2006 Dec;29(6):1453-8.

CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasion.

Fu Y, Zagozdzon R, Avraham R, Avraham HK.

Source

Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

Abstract

Among the most important signaling pathways operating in pancreatic cancer cells are those resulting from mutations in the Ras oncogene or from overexpression of ErbB-2 and associated Src-family kinases. In this study, we aimed to characterize CHK expression and function in pancreatic cancer. Our data demonstrated CHK expression in human pancreatic cancer tissues, and also showed that CHK associated with ErbB-2 via its SH2 domain in human PANC-1 pancreatic cancer cells. PANC-1 cells were found to express both Src kinase and Lyn kinase, although the expression of Lyn kinase was more abundant. Furthermore, CHK downregulated Lyn kinase activity and significantly inhibited the in vitro growth and invasion of PANC-1 cells upon EGF stimulation. These results indicate that CHK is a negative regulator of ErbB-2 and Lyn kinase signaling in pancreatic cancer cells.

PMID:: 17088984; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Spandidos Publications - PDF

Medical

Pancreatic Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation. [J Biol Chem. 1998]
Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.
Zrihan-Licht S, Deng B, Yarden Y, McShan G, Keydar I, Avraham H. J Biol Chem. 1998 Feb 13; 273(7):4065-72.
Functional analysis of Csk and CHK kinases in breast cancer cells. [J Biol Chem. 2001]
Functional analysis of Csk and CHK kinases in breast cancer cells.
Bougeret C, Jiang S, Keydar I, Avraham H. J Biol Chem. 2001 Sep 7; 276(36):33711-20. Epub 2001 Jul 9.
Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading. [J Biol Chem. 1998]
Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading.
Hirao A, Huang XL, Suda T, Yamaguchi N. J Biol Chem. 1998 Apr 17; 273(16):10004-10.
Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer. [J Biol Chem. 2002]
Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.
Kim S, Zagozdzon R, Meisler A, Baleja JD, Fu Y, Avraham S, Avraham H. J Biol Chem. 2002 Sep 27; 277(39):36465-70. Epub 2002 Jul 16.
Review [Pancreatic tumor: progress in diagnosis and treatment. Topics: I. Pancreatic carcinoma: 2. Pathogenesis and pathobiology in pancreatic cancer.--The molecular mechanisms of carcinogenesis, and invasion and metastasis in pancreatic cancer]. [Nihon Naika Gakkai Zasshi. 2012]
Review [Pancreatic tumor: progress in diagnosis and treatment. Topics: I. Pancreatic carcinoma: 2. Pathogenesis and pathobiology in pancreatic cancer.--The molecular mechanisms of carcinogenesis, and invasion and metastasis in pancreatic cancer].
Satoh K, Shimosegawa T. Nihon Naika Gakkai Zasshi. 2012 Jan 10; 101(1):7-16.

See reviews... See all...

Cited by 3 PubMed Central articles

Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression. [Br J Cancer. 2010]
Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression.
Elsberger B, Fullerton R, Zino S, Jordan F, Mitchell TJ, Brunton VG, Mallon EA, Shiels PG, Edwards J. Br J Cancer. 2010 Sep 7; 103(6):899-909. Epub 2010 Aug 17.
Review The role of Src in solid tumors. [Oncologist. 2009]
Review The role of Src in solid tumors.
Wheeler DL, Iida M, Dunn EF. Oncologist. 2009 Jul; 14(7):667-78. Epub 2009 Jul 6.
Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma. [Mol Cancer Ther. 2008]
Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
Guan H, Zhou Z, Gallick GE, Jia SF, Morales J, Sood AK, Corey SJ, Kleinerman ES. Mol Cancer Ther. 2008 Jul; 7(7):1807-16.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Protein Clusters
Clusters of related proteins from the Protein Clusters database that cite the current articles. Sources of references in Protein Clusters include the associated Gene and Conserved Domain records as well as NCBI added citations.
Domains
Conserved Domain Database (CDD) records that cite the current articles. Citations are from the CDD source database records (PFAM, SMART).
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasi...
CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasion.
Int J Oncol. 2006 Dec ;29(6):1453-8.

PubMed
Feeling pain? Who's your daddy....
Feeling pain? Who's your daddy....
Nat Med. 2006 Nov ;12(11):1243-4.

PubMed
Decreased risk of stroke among 10-year survivors of breast cancer.
Decreased risk of stroke among 10-year survivors of breast cancer.
J Clin Oncol. 2006 Dec 1 ;24(34):5388-94. Epub 2006 Nov 6 .

PubMed
Th17 functions as an osteoclastogenic helper T cell subset that links T cell act...
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.
J Exp Med. 2006 Nov 27 ;203(12):2673-82. Epub 2006 Nov 6 .

PubMed
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by...
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.
J Exp Med. 2006 Nov 27 ;203(12):2639-48. Epub 2006 Nov 6 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasion.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information